📣 VC round data is live. Check it out!
- Public Comps
- Cachet Pharmaceuticals
Cachet Pharmaceuticals Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cachet Pharmaceuticals and similar public comparables like Farmacias Benavides, Genky Drug Stores, Zjamp Group, JZJ Chain Drugstore and more.
Cachet Pharmaceuticals Overview
About Cachet Pharmaceuticals
Cachet Pharmaceutical Co Ltd is a state-owned stock company. Its main business includes: Medicine supply to hospitals, wholesaling of biological products, medical instruments, and traditional Chinese medicines. The Company also involved in pharmaceutical logistics and retail pharmacy chain.
Founded
1997
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$484M
Valuation Multiples
Start free trialCachet Pharmaceuticals Financials
Cachet Pharmaceuticals reported last fiscal year revenue of $3B and EBITDA of $66M.
In the same fiscal year, Cachet Pharmaceuticals generated $183M in gross profit, $66M in EBITDA, and $16M in net income.
Cachet Pharmaceuticals P&L
In the most recent fiscal year, Cachet Pharmaceuticals reported revenue of $3B and EBITDA of $66M.
Cachet Pharmaceuticals is profitable as of last fiscal year, with gross margin of 6%, EBITDA margin of 2%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Cachet Pharmaceuticals Stock Performance
Cachet Pharmaceuticals has current market cap of $590M, and enterprise value of $484M.
Market Cap Evolution
Cachet Pharmaceuticals' stock price is $2.02.
Cachet Pharmaceuticals share price increased by 0.1% in the last 30 days, and by 1.7% in the last year.
Cachet Pharmaceuticals has an EPS (earnings per share) of $0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $484M | $590M | 0.0% | 0.1% | -12.0% | 1.7% | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCachet Pharmaceuticals Valuation Multiples
Cachet Pharmaceuticals trades at 0.2x EV/Revenue multiple, and 7.4x EV/EBITDA.
Cachet Pharmaceuticals Financial Valuation Multiples
As of May 4, 2026, Cachet Pharmaceuticals has market cap of $590M and EV of $484M.
Cachet Pharmaceuticals has a P/E ratio of 36.1x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cachet Pharmaceuticals Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cachet Pharmaceuticals Margins & Growth Rates
In the most recent fiscal year, Cachet Pharmaceuticals reported gross margin of 6%, EBITDA margin of 2%, and net margin of 1%.
Cachet Pharmaceuticals Margins
Cachet Pharmaceuticals Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cachet Pharmaceuticals Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Cachet Pharmaceuticals Competitors
Cachet Pharmaceuticals competitors include Farmacias Benavides, Genky Drug Stores, Zjamp Group, JZJ Chain Drugstore, YSB, DocMorris, Cawachi, Dimed SA, Luyan Pharma and Shu Yu Civilian Pharmacy.
Most Cachet Pharmaceuticals public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.8x | — | 7.3x | — | |||
| 0.6x | 0.6x | 7.8x | 7.8x | |||
| 0.0x | — | 0.9x | — | |||
| 0.8x | — | 5.9x | — | |||
| 0.1x | — | 5.6x | — | |||
| 0.4x | 0.4x | (11.3x) | (10.8x) | |||
| 0.2x | 0.2x | 4.0x | — | |||
| 0.6x | 0.6x | 6.1x | 9.4x | |||
This data is available for Pro users. Sign up to see all Cachet Pharmaceuticals competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cachet Pharmaceuticals
| When was Cachet Pharmaceuticals founded? | Cachet Pharmaceuticals was founded in 1997. |
| Where is Cachet Pharmaceuticals headquartered? | Cachet Pharmaceuticals is headquartered in China. |
| Is Cachet Pharmaceuticals publicly listed? | Yes, Cachet Pharmaceuticals is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Cachet Pharmaceuticals? | Cachet Pharmaceuticals trades under 002462 ticker. |
| When did Cachet Pharmaceuticals go public? | Cachet Pharmaceuticals went public in 2010. |
| Who are competitors of Cachet Pharmaceuticals? | Cachet Pharmaceuticals main competitors include Farmacias Benavides, Genky Drug Stores, Zjamp Group, JZJ Chain Drugstore, YSB, DocMorris, Cawachi, Dimed SA, Luyan Pharma, Shu Yu Civilian Pharmacy. |
| What is the current market cap of Cachet Pharmaceuticals? | Cachet Pharmaceuticals' current market cap is $590M. |
| What is the current revenue of Cachet Pharmaceuticals? | Cachet Pharmaceuticals' last fiscal year revenue is $3B. |
| What is the current EV/Revenue multiple of Cachet Pharmaceuticals? | Current revenue multiple of Cachet Pharmaceuticals is 0.2x. |
| Is Cachet Pharmaceuticals profitable? | No, Cachet Pharmaceuticals is not profitable. |
| How many companies Cachet Pharmaceuticals has acquired to date? | Cachet Pharmaceuticals hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Cachet Pharmaceuticals has invested to date? | Cachet Pharmaceuticals hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Cachet Pharmaceuticals
Lists including Cachet Pharmaceuticals
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.